HopeStage
Back to all studies
CompletedNCT03775109

Blocking IL-1 Signals in Alcohol-Related Hepatitis

About this titleRead the official source — NCT03775109
Medication studyAges 18+United KingdomAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
Bristol and 15 more locationsSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: February 12, 2019
Recruitment status
Completed
Enrollment listed in the registry
55
Sponsor
Imperial College London
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United Kingdom
Age range
Over 18 Years
Official registry ID
NCT03775109
Official title
Show the full official title

IL-1 Signal Inhibition in Alcoholic Hepatitis (ISAIAH)

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Bristol · Glasgow · Leeds

7 more locations
  • Liverpool
  • London
  • Newcastle upon Tyne
  • Nottingham
  • Oxford
  • Plymouth
  • Southampton

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Imperial College London, a university.

Did this study involve medication?

Yes. The study involved medication, including Canakinumab 150mg/ml solution for injection and Placebo.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies